News
Eli Lilly & Co.’s experimental weight-loss pill helped patients shed pounds without serious side effects in a clinical trial, ...
The AstraZeneca PLC ADR AZN slid 1.14% to $69.95 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average DJIA rising 0.08% to ...
AstraZeneca PLC closed 22.38% below its 52-week high of £133.88, which the company achieved on September 3rd.
In a sign of the importance of some of the imports and the damaging effect disruption could have on China's healthcare ...
Companies like AstraZeneca, Daiichi Sankyo, Pfizer and Merck are learning from previous setbacks in the ADC space to improve ...
New Report Highlights Emerging Leaders Advancing Next-generation Radiopharmaceuticals, Reshaping Cancer Care Through Targeted ...
Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the release of a new ...
AstraZeneca said on Friday it has agreed to a research deal with Chinese drugmaker CSPC Pharmaceuticals worth up to $5.22 ...
AstraZeneca has signed a research agreement worth more than US$5 billion with Chinese drugmaker CSPC Pharmaceutical Group, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results